Document:

Exhibit 4(b)(3)

 

FACE OF SECURITY.

 

THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE
HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITARY OR A
NOMINEE THEREOF. THIS SECURITY MAY NOT BE EXCHANGED IN WHOLE OR IN PART FOR A
SECURITY REGISTERED, AND NO TRANSFER OF THIS SECURITY IN WHOLE OR IN PART MAY
BE REGISTERED, IN THE NAME OF ANY PERSON OTHER THAN SUCH DEPOSITARY OR A
NOMINEE THEREOF, EXCEPT IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE
INDENTURE.

 

OVERSEAS SHIPHOLDING GROUP, INC.

 

8 3/4% DEBENTURES DUE DECEMBER 1,
2013

 

 

 

	
   

  	
   

  	
  CUSIP NO. 690368AB1

  
	
  No. R-1

  	
   

  	
  $100,000,000

  

 

Overseas Shipholding Group, Inc., a corporation duly organized and
existing under the laws of Delaware (herein called the “Company”, which term
includes any successor Person under the Indenture hereinafter referred to), for
value received, hereby promises to pay to CEDE & CO. or registered assigns,
the principal sum of ONE HUNDRED MILLION DOLLARS ($100,000,000) on
December 1, 2013, and to pay interest thereon from December 1, 1993
or from the most recent Interest Payment Date to which interest has been paid
or duly provided for, semi-annually on June 1 and December 1 in each
year, commencing June 1, 1994, at the rate of 8 3/4% per annum, until
the principal hereof is paid or made available for payment. The interest so
payable, and punctually paid or duly provided for, on any Interest Payment Date
will, as provided in such Indenture, be paid to the Person in whose name this
Security (or one or more Predecessor Securities) is registered at the close of
business on the Regular Record Date for such interest, which shall be the May
15 or November 15 (whether or not a Business Day), as the case may be,
next preceding such Interest Payment Date. Any such interest not so punctually
paid or duly provided for will forthwith cease to be payable to the Holder on
such Regular Record Date and may either be paid to the Person in whose name
this Security (or one or more Predecessor Securities) is registered at the
close of business on a Special Record Date for the payment of such Defaulted
Interest to be fixed by the Trustee, notice whereof 

 

 

shall be given to Holders of Securities of this series not less than
10 days prior to such Special Record Date, or be paid at any time in any
other lawful manner not inconsistent with the requirements of any securities
exchange on which the Securities of this series may be listed, and upon such
notice as may be required by such exchange, all as more fully provided in said
Indenture.

 

Payment of the principal of (and premium, if any) and interest on this
Security will be made at the office or agency of the Company maintained for
that purpose in The City of New York, in such coin or currency of the United
States of America as at the time of payment is legal tender for payment of
public and private debts.

 

Reference is hereby made to the further provisions of this Security set
forth on the reverse hereof, which further provisions shall for all purposes
have the same effect as if set forth at this place.

 

Unless the certificate of authentication hereon has been executed by
the Trustee referred to on the reverse hereof by manual signature, this
Security shall not be entitled to any benefit under the Indenture or be valid
or obligatory for any purpose.

 

IN WITNESS WHEREOF, the Company has caused this instrument to be duly
executed under its corporate seal.

 

Dated: December 9, 1993

 

	
  [Seal]

  	
  Overseas Shipholding Group, Inc.

  
	
   

  	
   

  
	
   

  	
  By 

  	
  /s/ Gabriel Kahana

  	
   

  
	
   

  	
   

  	
  Name:

  	
  Gabriel Kahana

  
	
   

  	
   

  	
  Title:

  	
  Senior Vice President

  and Treasurer

  
	
   

  	
   

  
	
  Attest:

  	
   

  
	
   

  	
   

  
	
            /s/
  Robert N. Cowen

  	
   

  	
   

  
	
  Name:

  	
  Robert N. Cowen

  	
   

  
	
  Title: 

  	
  Senior Vice President,

  	
   

  
	
   

  	
  Secretary and General Counsel

  	
   

  
								

 

 

Unless this certificate is presented by an authorized representative of
The Depository Trust Company, a New York corporation (“DTC”), to Issuer or its
agent for registration of transfer, exchange, or payment, and any certificate
issued is registered in the name of Cede & Co. or in such other name as is
requested by an authorized representative of DTC (and any payment is made to
Cede & Co. or to such other entity as is requested by an authorized
representative of DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR
OTHERWISE BY OR TO ANY PERSON IS WRONGFUL inasmuch as the registered owner
hereof, Cede & Co., has an interest herein.

 

This is one of the Securities of the series designated therein referred
to in the within-mentioned Indenture.

 

	
   

  	
   

  	
  THE CHASE MANHATTAN BANK

  
	
   

  	
   

  	
       (NATIONAL ASSOCIATION),

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  As Trustee

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
   

  	
  /s/ Ann L. Edmonds

  	
   

  
	
   

  	
   

  	
   

  	
  Authorized Officer

  	
   

  

 

3

 

REVERSE OF SECURITY.

 

This Security is one of a duly authorized issue of securities of the
Company (herein called the “Securities”), 
issued and to be issued in one or more series under an Indenture, dated
as of December 1, 1993, (herein called the “Indenture”, which term shall
have the meaning assigned to it in such instrument), between the Company and
The Chase Manhattan Bank (National Association), as Trustee (herein called the
“Trustee”, which term includes any successor trustee under the Indenture), and
reference is hereby made to the Indenture for a statement of the respective
rights, limitations of rights, duties and immunities thereunder of the Company,
the Trustee and the Holders of the Securities and of the terms upon which the
Securities are, and are to be, authenticated and delivered. This Security is
one of the series designated on the face hereof, limited in aggregate principal
amount to $100,000,000.

 

The Securities of this series may be redeemed at the Company’s option,
in whole or from time to time in part, upon not less than 30 nor more than 60
days’ notice mailed to each Holder of Securities to be redeemed at the address
of such Holder appearing in the Security Register, on any date prior to
maturity at (i) a Redemption Price equal to 100% of the principal amount
thereof plus (ii) accrued interest to the Redemption Date (subject to the right
of Holders of record on the relevant Regular Record Date to receive interest
due on an Interest Payment Date that is on or prior to the Redemption Date),
plus (iii) a Make-Whole Premium, if any.

 

The amount of the Make-Whole Premium in respect of the principal amount
of this Security to be redeemed shall be the excess, if any, of (i) the
sum of the present values, as of the Redemption Date of this Security, of (A)
the respective interest payments (exclusive of the amount of accrued interest
to the Redemption Date) on this Security that, but for such redemption, would
have been payable on their respective Interest Payment Dates after such
Redemption Date, and (B) the payment of such principal amount that, but
for such redemption, would have been payable at maturity over (ii) the
amount of such principal to be redeemed. 
Such present values will be determined in accordance with generally
recognized principles of financial analysis by discounting the amounts of such
payments of interest and principal from their respective Stated Maturities to
such Redemption Date at a discount rate equal to the Treasury Yield.

 

The Make-Whole Premium shall be calculated by an independent investment
banking institution of national standing appointed by the Company, which may be
one of the Underwriters named in the

 

4

 

Prospectus Supplement, dated December 2, 1993; provided, that if
the Company fails to make such appointment at least 10 days prior to the
Redemption Date, or if the institution so appointed is unwilling or unable to
make such calculation, such calculation will be made by Goldman, Sachs &
Co. or, if Goldman, Sachs & Co. is unwilling or unable to make such
calculation, by an independent investment banking institution of national
standing appointed by the Trustee (in any such case, an “Independent Investment
Banker”).

 

For purposes of determining the Make-Whole Premium, “Treasury Yield”
means a rate of interest per annum, determined by the Independent Investment
Banker as of the third Business Day preceding the applicable Redemption Date,
equal to the weekly average yield to maturity of United States Treasury Notes
having a constant maturity as set forth in the most recent weekly statistical
release (or any successor release) published by the Federal Reserve Bank of New
York and designated “H.15(519) Selected Interest Rates” (the “H.15 Statistical
Release”) corresponding to the remaining term of this Security (calculated to
the nearest 1/12 of a year) (the “Remaining Term”); such yield to be calculated
by the Independent Investment Banker, by interpolation (unless the Remaining
Term of this Security equals a constant maturity set forth in the H.15
Statistical Release) on a straight-line basis, between the weekly average
yields (rounded, if necessary, to four decimal places) on (a) the United States
Treasury Notes with a constant maturity closest to and greater than the
Remaining Term and (b) the United States Treasury Notes with a constant
maturity closest to and less than the Remaining Term, or if such weekly average
yields are not available, by interpolation of comparable rates selected by the
Independent Investment Banker.

 

In the event of redemption of this Security in part only, a new
Security or Securities of this series and of like tenor for the unredeemed
portion hereof will be issued in the name of the Holder hereof upon the
cancellation hereof.

 

The Indenture contains provisions for defeasance at any time of the
entire indebtedness of this Security or certain restrictive covenants and
Events of Default with respect to this Security, in each case upon compliance
with certain conditions set forth in the Indenture.

 

If an Event of Default with respect to Securities of this series shall
occur and be continuing, the principal of the Securities of this series may be
declared due and payable in the manner and with the effect provided in the
Indenture.

 

5

 

The Indenture permits, with certain exceptions as therein provided, the
amendment thereof and the modification of the rights and obligations of the
Company and the rights of the Holders of the Securities of each series to be
affected under the Indenture at any time by the Company and the Trustee with
the consent of the Holders of 66 2/3% in principal amount of the
Securities at the time Outstanding of each series to be affected. The Indenture
also contains provisions permitting the Holders of specified percentages in
principal amount of the Securities of each series at the time Outstanding, on
behalf of the Holders of all Securities of such series, to waive compliance by
the Company with certain provisions of the Indenture and certain past defaults
under the Indenture and their consequences. Any such consent or waiver by the
Holder of this Security shall be conclusive and binding upon such Holder and
upon all future Holders of this Security and of any Security issued upon the
registration of transfer hereof or in exchange herefor or in lieu hereof,
whether or not notation of such consent or waiver is made upon this Security.

 

As provided in and subject to the provisions of the Indenture, the
Holder of this Security shall not have the right to institute any proceeding
with respect to the Indenture or for the appointment of a receiver or trustee
or for any other remedy thereunder, unless such Holder shall have previously
given the Trustee written notice of a continuing Event of Default with respect
to the Securities of this series, the Holders of not less than 25% in principal
amount of the Securities of this series at the time Outstanding shall have made
written request to the Trustee to institute proceedings in respect of such
Event of Default as Trustee and offered the Trustee reasonable indemnity, and
the Trustee shall not have received from the Holders of a majority in principal
amount of Securities of this series at the time Outstanding a direction
inconsistent with such request, and shall have failed to institute any such
proceeding, for 60 days after receipt of such notice, request and offer of
indemnity. The foregoing shall not apply to any suit instituted by the Holder
of this Security for the enforcement of any payment of principal hereof or any
premium or interest hereon on or after the respective due dates expressed
herein.

 

No reference herein to the Indenture and no provision of this Security
or of the Indenture shall alter or impair the obligation of the Company, which
is absolute and unconditional, to pay the principal of and any premium and
interest on this Security at the times, place and rate, and in the coin or
currency, herein prescribed.

 

6

 

As provided in the Indenture and subject to certain limitations therein
set forth, the transfer of this Security is registrable in the Security
Register, upon surrender of this Security for registration of transfer at the
office or agency of the Company in any place where the principal of and any
premium and interest on this Security are payable, duly endorsed by, or
accompanied by a written instrument of transfer in form satisfactory to the
Company and the Security Registrar duly executed by, the Holder hereof or his
attorney duly authorized in writing, and thereupon one or more new Securities
of this series and of like tenor, of authorized denominations and for the same
aggregate principal amount, will be issued to the designated transferee or
transferees.

 

The Securities of this series are issuable only in registered form
without coupons in denominations of $1000 and any integral multiple thereof. As
provided in the Indenture and subject to certain limitations therein set forth,
Securities of this series are exchangeable for a like aggregate principal
amount of Securities of this series and of like tenor of a different authorized
denomination, as requested by the Holder surrendering the same.

 

No service charge shall be made for any such registration of transfer
or exchange, but the Company may require payment of a sum sufficient to cover
any tax or other governmental charge payable in connection therewith.

 

Prior to due presentment of this Security for registration of transfer,
the Company, the Trustee and any agent of the Company or the Trustee may treat
the Person in whose name this Security is registered as the owner hereof for
all purposes, whether or not this Security be overdue, and neither the Company,
the Trustee nor any such agent shall be affected by notice to the contrary.

 

All terms used in this Security which are defined in the Indenture
shall have the meanings assigned to them in the Indenture.

 

7Exhibit
10.1

 

AMENDMENT
No. 2

 

This
Amendment No. 2, dated, March 11, 2004 to the Master Agreement effective
February 1, 2000, and amended as of December 20, 2001  (hereinafter
referred to as “the Agreement”) between Laboratory Corporation of America
Holdings (hereinafter referred to as “LabCorp”) and Cytyc
Corporation (hereinafter referred to as “Cytyc”). LabCorp and Cytyc
are collectively referred to herein as the “Parties.”

 

WHEREAS, the Parties
desire to amend the Agreement, effective 
January 1, 2002.

 

NOW THEREFORE, in
consideration of the agreements, mutual representations and covenants contained
herein and for other good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, the Parties hereby agree as
follows:

 

1.                                       This Amendment No. 2 (“This Amendment”)
constitutes an amendment to the Agreement pursuant to the provisions of
Section H of the Agreement.

 

2.                                       The
following Schedules are attached hereto and incorporated herein by reference:

            •                                          Schedule A
– LabCorp facilities that will be incorporated into the Agreement, which may be
modified by LabCorp from time to time as a result of consolidations and new
acquisitions by providing written notice to Cytyc.

            •                                          Schedule B
– The Schedule of LabCorp ThinPrep 2000s Earned and Placed as of
December 31, 2003 which will be modified during the term of the Agreement
as set forth in this Amendment.

 

3.                                       Paragraph
5 of Amendment No. 1 is hereby deleted in its entirety and replaced with the
following Paragraph 5:

 

5.                                         INSTRUMENTATION:  Effective January 1, 2002, and
continuing throughout the remainder of the term of the Agreement, Cytyc shall
provide to LabCorp ThinPrep 2000 Processors (“T-2000”) under the following
terms and conditions:

 

a)                                      All
T-2000s placed at LabCorp facilities on or AFTER January 1, 2002 shall be
included in the fees paid by LabCorp to Cytyc for ThinPrep Pap Test Laboratory
Supplies as more specifically set forth in paragraph 7 of Amendment No. 1.

 

b)                                     All
T-2000s placed at LabCorp facilities prior to January 1, 2002, AND for
which LabCorp has not previously paid Cytyc an equipment purchase fee shall
also be included in the  fees paid by
LabCorp to Cytyc for ThinPrep Pap Test Laboratory Supplies effective
January 1, 2002 as more specifically set forth in paragraph 7 Amendment
No. 1.

 

c)                                      Subsequent
to January 1, 2002, in order to accommodate growth in test volume, Cytyc
shall provide to LabCorp facilities additional T-2000s as follows: Each time
the utilization of Cytyc’s ThinPrep PapTest in any three (3) month consecutive
period equals or exceeds Test utilization over the Baseline Period (as defined
in (e) below) by XXXX or more Tests (XXXX Tests on average per month) for that
LabCorp facility, Cytyc shall provide an additional T-2000 at such facility at
no charge.

 

 

AMENDMENT
No. 2

Dated
March 10, 2004

 

d)                                     Upon
specific written notification by LabCorp of expected volume increases (meeting
the XXXX Test on average per month volume increase as outlined in 5.c) above)
at any facility due to new contracts, client accounts or LabCorp acquisition,
Cytyc will place the T-2000 in advance of
the three (3) month consecutive period. 
Both parties agree to review the actual growth volume achieved after a
reasonable period in order to insure that the sustained three (3) month volume set
forth in 5.c) above is achieved.  If
not, LabCorp, at its option, will either pay Cytyc $XXXX for the T-2000(s) or
relocate the T-2000(s) to another facility having earned T-2000(s) and notify
Cytyc of the relocation.

 

e)                                      The
Baseline Period shall be determined as follows:

i)    Original Baseline Period: As of
January 1, 2002, The Baseline Period for each LabCorp facility, for
purposes of c) above, shall be the actual Test utilization by such facility in
the last three (3) calendar months of 2001.

ii)   The
Baseline Period for each LabCorp facility, as defined above, shall be  updated each time  a T-2000 is earned at such facility after January 1, 2002 in
accordance with the requirements of part 5.c) above.  The updated Baseline Period shall be the actual Test utilization
by such facility in the last three (3) month period which resulted in LabCorp
earning an additional  T-2000 at that
facility.

 

f)                                        LabCorp
shall provide Cytyc with monthly Test utilization reports  for each LabCorp facility by the 20th
day of the following month in order for the Parties to determine if an
additional   T-2000 will be placed at
any LabCorp facilities pursuant to c) above. 
Cytyc, upon reasonable prior request, may visit LabCorp facilities to
evaluate productivity of T-2000s at such facilities and provide feedback to
LabCorp on such evaluation.

 

g)                                     During
the term of the Agreement, Cytyc shall maintain title to any T-2000s provided
to LabCorp in accordance with this Amendment. 
LabCorp has the right to purchase any T-2000 placed by Cytyc at no
charge in accordance with the provisions of Paragraph 6 of Amendment #1, as
amended by Section  4 of this Amendment #2.

 

h)                                     LabCorp
shall be responsible for service costs as set forth in the Equipment Addendum
to the Agreement.

 

i)                                         The
Parties acknowledge and agree to the following with respect to placement of
T-2000s from January 1, 2002 through December 31, 2003:

i)    Cytyc placed XXXX T-2000s at LabCorp
facilities specified in the attached Schedule B under the heading “Placed
through December 31, 2003.”

ii)   In accordance with part c) above, during
Calendar years 2002 and 2003 (through and including December 31, 2003)
Cytyc will provide an additional XXXX T-2000s at the locations and in the
allocations specified in the attached Schedule B under the heading “Earned
through December 31, 2003.”

 

 

AMENDMENT
No. 2

Dated
March 10, 2004

 

iii)  With regard to the XXXX T-2000s earned
during Calendar Years 2002 and 2003, the Baseline Period for the respective
LabCorp facilities at which such T-2000s were earned was updated to reflect the
Test utilization for the three (3) month period prior to earning of the T-2000
in that facility  in accordance with 5
e)ii above.

iv)   Cytyc will agree to carryover into 2004 and
to place, upon LabCorp’s request, the remaining XXXX T-2000s earned.

 

j)                                               During
the remainder of the term of the Agreement, Schedule B will be updated
quarterly by mutual agreement of the parties to reflect T-2000s previously
placed, T-2000s earned and the Baseline for each LabCorp facility.   LabCorp will provide all information
necessary to prepare the report on a quarterly basis.  Cytyc will provide the report to LabCorp no more than ten (10)
business days after the receipt of the necessary information from LabCorp.

 

k)                                            LabCorp
may purchase additional T-2000 in accordance with the Equipment Addendum to the
Master Agreement

 

l)                                               Labcorp
may purchase a ThinPrep 3000 Processor (“T-3000”) in accordance with the
Equipment Addendum to the Agreement

 

4.                                       Paragraph
6 of Amendment No. 1 is hereby deleted in its entirety and replaced with the
following Paragraph 6:

 

6.                                                                                  PURCHASE
RIGHT:  Upon termination of this
Agreement, LabCorp shall have the right to purchase any T-2000 placed pursuant
to paragraphs 5(b),5(c) and 5(d) above at a cost of $XXXX per T-2000.  In the event LabCorp elects to purchase such
T-2000 it shall provide Cytyc 15 days notice. 
Upon payment of the purchase price, Cytyc shall convey to LabCorp all
right, title, and interest to the purchased T-2000(s) free and clear of all
liens and encumbrances.

 

5.                                       The
Parties expressly agree that there are no other understandings, writings or
discussions related to the subject matter hereof other than the Agreement as
amended by Amendment No. 1 and this Amendment No. 2, including Schedules A and
B.

 

6.                                       Except
as expressly modified by this Amendment No. 2, the Agreement as previously
amended shall continue in full force and effect in accordance with its
terms.  In the event of any conflict
between this Amendment and the terms of the Agreement as previously amended,
the terms of this Amendment shall prevail

 

 

AMENDMENT
No. 2

Dated
March 10, 2004

 

IN WITNESS
WHEREOF, the parties hereto have caused this Amendment No. 2 to the Agreement
to be executed by their fully authorized representative.

 

 

	
  LABORATORY CORPORATION OF AMERICA HOLDINGS

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
  By:

  	
   

  	
   

  	
  Date:

  	
   

  
	
   

  	
  Susan Barber

  	
   

  	
   

  
	
   

  	
  Vice President &
  Director

  	
   

  	
   

  
	
   

  	
  Science and Technology

  	
   

  	
   

  
					

 

 

	
  CYTYC CORPORATION

  
	
   

  
	
   

  
	
  By:

  	
   

  	
   

  	
  Date:

  
	
   

  	
  Christopher Bleck

  	
   

  
	
   

  	
  Vice President
  Commercial Operations

  	
   

  

 

 

SCHEDULE A

 

LABCORP
FACILITIES

 

	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  
	
  XXXX

  	
   

  

 

 

SCHEDULE B

 

LabCorp T2 Shipments

YTD as of December 31, 2003

Shipped vs Earned Instruments Jan
2002 thru December 2003

“Schedule B”

 

	
  Location

  	
   

  	
  Earned through

  12/31/03

  	
   

  	
  Placed through

  12/31/03

  	
   

  	
  Variance

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Total

  	
   

  	
  XXXX

  	
   

  	
  XXXX

  	
   

  	
  XXXX

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00065-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00065-of-00352.parquet"}]]